Ptc Therapeutics (PTCT) Short-term Investments (2013 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Short-term Investments of $1.2 billion for Q2 2026, up 21.35% year-over-year from $971.8 million in Q2 2025, and up 11.4% quarter-over-quarter from $1.1 billion in Q1 2026.
Ptc Therapeutics (PTCT) Short-term Investments (2013 - 2026) Analysis & Trends
Ptc Therapeutics' Short-term Investments history runs 14 years deep, the most recent figure standing at $1.2 billion for Q2 2026.
- In Q2 2026, Short-term Investments rose 21.35% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 21.35% YoY), while the FY2025 annual figure was $960.7 million, up 166.88% from the prior year.
- Short-term Investments for Q2 2026 stood at $1.2 billion, up from $1.1 billion in the prior quarter.
- The five-year high for Short-term Investments was $1.2 billion in Q2 2026, with the low at $118.8 million in Q1 2023.
- The 5-year median for Short-term Investments is $399.3 million (2024), against an average of $506.7 million.
- The sharpest annual moves came in 2022 and 2024: Short-term Investments sank 77.58% in 2022, then soared 275.89% in 2024.
- Ptc Therapeutics' Short-term Investments stood at $130.9 million in 2022, then soared by 116.04% to $282.7 million in 2023, then advanced by 27.32% to $360.0 million in 2024, then soared by 166.88% to $960.7 million in 2025, then increased by 22.74% to $1.2 billion in 2026.
- Business Quant data shows PTCT's Short-term Investments at $1.2 billion in Q2 2026, $1.1 billion in Q1 2026, and $960.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.06 Bn |
| Dec 31, 2025 | 960.72 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 971.76 Mn |
| Mar 31, 2025 | 546.95 Mn |
| Dec 31, 2024 | 359.99 Mn |
| Sep 30, 2024 | 487.36 Mn |
| Jun 30, 2024 | 438.51 Mn |
| Mar 31, 2024 | 336.46 Mn |
| Dec 31, 2023 | 282.74 Mn |
| Sep 30, 2023 | 129.65 Mn |
| Jun 30, 2023 | 129.55 Mn |
| Mar 31, 2023 | 118.81 Mn |
| Dec 31, 2022 | 130.87 Mn |
| Sep 30, 2022 | 184.01 Mn |
| Jun 30, 2022 | 347.39 Mn |
| Mar 31, 2022 | 443.62 Mn |
| Dec 31, 2021 | 583.66 Mn |
| Sep 30, 2021 | 678.13 Mn |